Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled crossover trial of Hexalacton (spironolactone) in type 1 diabetes with microalbuminuria
2008-004839-38Phase 4Completed
- Sponsor
- Steno Diabetes Center
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of spironolactone in diabetes mellitus type 1 (T1D) and diabetic glomerulosclerosis (2 arms), sponsored by Steno Diabetes Center. Primary endpoint: Albuminuria change. Started Nov 2008; status: completed.
02
Drugs
spironolactone
03
Conditions
diabetes mellitus type 1 (T1D)diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2008-004839-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004839-38.